头颈部NUT中线癌的系统综述与汇总生存分析
该系统综述纳入81篇病例报告,共138例用于人口学分析、65例用于生存分析,评估原发部位对头颈部NUT中线癌总生存的影响。气管喉咽部肿瘤总生存有更差趋势(HR 2.45,95%CI 1.01-5.95,p=0.047),BRD4-NUTM1融合与更差总生存相关(HR 8.3,95%CI 4.26-16.23,p=0.0003)。
要点
- 头颈部NUT中线癌预后差,BRD4-NUTM1融合提示更差生存
- 气管喉咽部原发肿瘤总生存有更差趋势
- 原发部位可能是潜在预后变量,可指导未来研究
核心结论
- 头颈部NUT中线癌预后差,BRD4-NUTM1融合者结局更差。
- 原发部位是潜在预后变量,可能为未来研究提供信息。
研究设计与样本
- 系统综述病例报告,261篇筛选文献中81篇符合纳入标准。
- 138例纳入人口学分析,65例纳入生存分析。
- 采用Kaplan-Meier生存分析评估不同亚部位、年龄和遗传特征的总生存差异。
主要发现
- 气管喉咽部肿瘤总生存有更差趋势(HR 2.45,95%CI 1.01-5.95,p=0.047)。
- 眶-鼻窦肿瘤总生存有改善趋势(HR 0.75,95%CI 0.46-1.24,p=0.25)。
- BRD4-NUTM1融合与更差总生存相关(HR 8.3,95%CI 4.26-16.23,p=0.0003)。
临床怎么用
- 对头颈部NUT中线癌患者,BRD4-NUTM1融合状态可用于预后分层。
- 原发部位信息有助于评估预后趋势,但需结合其他因素综合判断。
局限性
- 基于病例报告的系统综述,可能存在发表偏倚和选择偏倚。
- 生存分析样本量较小(65例),部分亚组比较的置信区间较宽。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: NUT midline carcinoma (NMC) is an aggressive malignancy driven by NUTM1 fusions in poorly differentiated tumor cells. This pooled analysis evaluates the impact of primary tumor location on overall survival (OS) in head and neck (HN) NMC. METHODS: A systematic review of case reports was performed. Kaplan-Meier survival analysis was used to assess OS differences by subsite, age, and genetic profile. RESULTS: Of 261 screened articles, 81 met inclusion criteria. Overall, 138 cases were included in demographic analyzes and 65 in survival analyzes. Tracheo-laryngopharyngeal tumors trended toward worse OS (HR 2.45, 95% CI 1.01-5.95, p = 0.047). Orbito-sinonasal tumors trended toward improved OS (HR 0.75, 95% CI 0.46-1.24, p = 0.25). BRD4-NUTM1 fusions were associated with worse OS (HR 8.3, 95% CI 4.26-16.23, p = 0.0003). CONCLUSIONS: HN NMC carries a poor prognosis, and BRD4-NUTM1 fusions have worse outcomes. Primary subsite is a potential prognostic variable that may inform future studies.
引用
- Yoon M, Ramirez R, Smith H, et al. NUT Midline Carcinoma of the Head and Neck: A Systematic Review and Pooled Survival Analysis. Head Neck. 2026. PMID: 42175568. doi:10.1002/hed.70328
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。